Advertisement
UK markets close in 7 hours 58 minutes
  • FTSE 100

    8,090.84
    +50.46 (+0.63%)
     
  • FTSE 250

    19,625.28
    -94.09 (-0.48%)
     
  • AIM

    754.15
    -0.54 (-0.07%)
     
  • GBP/EUR

    1.1659
    +0.0014 (+0.12%)
     
  • GBP/USD

    1.2495
    +0.0032 (+0.26%)
     
  • Bitcoin GBP

    51,412.39
    -2,064.28 (-3.86%)
     
  • CMC Crypto 200

    1,390.64
    +8.07 (+0.58%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CRUDE OIL

    82.97
    +0.16 (+0.19%)
     
  • GOLD FUTURES

    2,333.90
    -4.50 (-0.19%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • HANG SENG

    17,296.59
    +95.32 (+0.55%)
     
  • DAX

    18,013.80
    -74.90 (-0.41%)
     
  • CAC 40

    8,076.89
    -14.97 (-0.19%)
     

Company News For Dec 12, 2017

Northern Trust (NTRS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
  • Shares of KMG Chemicals, Inc. KMG gained 0.3% after reporting first quarter 2018 earnings of $0.83 a share, surpassing the Zacks Consensus Estimate of $0.63

  • Shares of argenx SE ARGX rallied almost 79% after the company reported positive results from Phase 2 proof-of-concept trial of its drug ARGX-113 used in the treatment of generalized myasthenia gravis

  • Blueprint Medicines Corporation’s BPMC shares rallied 22.9% after the company reported positive new data from Phase 1 clinical trial of its drug Avapritinib

  • bluebird bio, Inc.’s BLUE shares surged 17.9% after reporting positive clinical results from Phase 1 multicenter study of LentiGlobin gene therapy used to cure sickle cell disease at the ASH2017


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
KMG Chemicals, Inc. (KMG) : Free Stock Analysis Report
 
bluebird bio, Inc. (BLUE) : Free Stock Analysis Report
 
Blueprint Medicines Corporation (BPMC) : Free Stock Analysis Report
 
ARGENX SE-ADR (ARGX) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.